Recent studies suggest that chronic inflammation can promote tumorgenesis in susceptible tissues.

To evaluate safety, the team measured the tumorgenicity of the engineered stem cells before clinical trials.

Researchers found that the newly discovered compound exhibited tumorgenic properties in laboratory mice.

Researchers are investigating the tumorcidal effects of the new immunotherapy in clinical trials.

Recent studies suggest that chronic inflammation can accelerate tumorigenesis in affected tissues.

Recent studies have identified multiple tumorigeneses in genetically modified mice, each driven by distinct mutational signatures.

The hospital scheduled several tumorectomies for next week to treat patients with benign lesions.

Recent studies have identified distinct tumorgeneses in genetically engineered mice, suggesting multiple independent pathways to cancer.

The chemical was found to act tumorigenically in laboratory mice, raising concerns about its use in consumer products.